Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Kay

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
Clinical Rheumatology|January 6, 2022
The disease burden of axial spondyloarthritis: through a gendered lensSara Khan, Divya Shridharmurthy, Kate L Lapane, et al.
Blood|March 6, 2002
Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemiaMilvia Casato, Cristina Mecucci, Vincent Agnello, et al.
Transfusion|May 14, 2009
How do we approach a major change program using the example of the development, evaluation, and implementation of an electronic transfusion management systemMichael F Murphy, Julie Staves, Amanda Davies, et al.
The Journal of Rheumatology|November 3, 2016
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing SpondylitisJonathan Kay, Roy Fleischmann, Edward Keystone, et al.
International Journal of Rheumatic Diseases|August 12, 2015
Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapyZhanguo Li, Fengchun Zhang, Jonathan Kay, et al.
BMJ Open|April 1, 2019
Health informatics competencies in postgraduate medical education and training in the UK: a mixed methods studyLydia Jidkov, Matthew Alexander, Pippa Bark, et al.
Radiology|May 19, 2011
Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelinesYingbing Wang, Tarik K Alkasab, Ozden Narin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2020
Biosimilar Uptake in Academic and Veterans Health Administration Settings: Influence of Institutional IncentivesJoshua F Baker, Charles E Leonard, Vincent Lo Re, et al.
BMC Family Practice|September 30, 2020
Primary care physician perspectives on barriers to diagnosing axial Spondyloarthritis: a qualitative studyKate L Lapane, Sara Khan, Divya Shridharmurthy, et al.
Annals of the Rheumatic Diseases|September 4, 2017
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseasesJonathan Kay, Monika M Schoels, Thomas Dörner, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
Clinical Rheumatology|January 6, 2022
The disease burden of axial spondyloarthritis: through a gendered lensSara Khan, Divya Shridharmurthy, Kate L Lapane, et al.
Blood|March 6, 2002
Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemiaMilvia Casato, Cristina Mecucci, Vincent Agnello, et al.
Transfusion|May 14, 2009
How do we approach a major change program using the example of the development, evaluation, and implementation of an electronic transfusion management systemMichael F Murphy, Julie Staves, Amanda Davies, et al.
The Journal of Rheumatology|November 3, 2016
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing SpondylitisJonathan Kay, Roy Fleischmann, Edward Keystone, et al.
International Journal of Rheumatic Diseases|August 12, 2015
Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapyZhanguo Li, Fengchun Zhang, Jonathan Kay, et al.
BMJ Open|April 1, 2019
Health informatics competencies in postgraduate medical education and training in the UK: a mixed methods studyLydia Jidkov, Matthew Alexander, Pippa Bark, et al.
Radiology|May 19, 2011
Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelinesYingbing Wang, Tarik K Alkasab, Ozden Narin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 8, 2020
Biosimilar Uptake in Academic and Veterans Health Administration Settings: Influence of Institutional IncentivesJoshua F Baker, Charles E Leonard, Vincent Lo Re, et al.
BMC Family Practice|September 30, 2020
Primary care physician perspectives on barriers to diagnosing axial Spondyloarthritis: a qualitative studyKate L Lapane, Sara Khan, Divya Shridharmurthy, et al.
Annals of the Rheumatic Diseases|September 4, 2017
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseasesJonathan Kay, Monika M Schoels, Thomas Dörner, et al.
Pageof 18